Baldness Increases PCa Risk
Androgenic alopecia, also known as male pattern baldness, is significantly associated with an elevated risk for prostate cancer (PCa).
AUA 2012 Annual Meeting
New Assay Identifies Men Who May Be at Lower Risk for PCa Recurrence After Surgery
A recently approved diagnostic assay may improve clinicians’ ability to predict a prostate cancer patient’s risk of clinical recurrence after radical prostatectomy (RP), a company announced at the American Urological Association 2012 annual meeting.
Oral Drug Prolongs Survival in Men with Late-Stage PCa
Enzalutamide, an investigational oral medication formerly known as MDV3100, prolongs survival by nearly five months in men with late-stage prostate cancer previously treated with docetaxel, according to data presented at the American Urological Association 2012 annual meeting.
Healthy Diet May Protect Against LUTS
Healthy eating may lower the risk of lower urinary tract symptoms (LUTS), according to data presented at the American Urological Association 2012 annual meeting.
Fesoterodine Relieves Nocturnal Urgency in OAB Patients
Flexible-dose fesoterodine is superior to placebo in decreasing the number of nocturnal urgency episodes and nocturnal micturitions in patients with overactive bladder (OAB), researchers reported at the American Urological Association 2012 annual meeting.
OAB Patients Most Bothered by Urgency
Patients with overactive bladder (OAB) say they are most bothered by symptoms of urinary urgency either as a primary complaint or as a driving symptom for frequency, according to a pilot study presented at the American Urological Association 2012 annual meeting.
BoNTA Safe, Effective for Diabetic OAB Patients
Diabetes has no influence on intravesical botulinum toxin type A (BoNTA) injection in overactive bladder (OAB) patients, researchers reported at the American Urological Association 2012 annual meeting.
Novel Catheter May Prevent Patient Injuries
Researchers have developed a novel catheter that they say can cut down on the number of catheter-related injuries, according to a presentation at the American Urological Association 2012 annual meeting.
Intermittent ADT May Offer Survival Edge in Advanced Prostate Cancer
Intermittent androgen deprivation (IAD) therapy is associated with improved all-cause and prostate cancer (PCa)-specific mortality among elderly patients with advanced PCa, according to data presented at the American Urological Association 2012 annual meeting.
Pyuria, Microhematuria Duration After Prostate Surgery Quantified
Pyuria persists longer than microhematuria after prostatic surgery and it is significantly associated with resected prostate weight, according to a study presented at the American Urological Association 2012 annual meeting.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...